Immune reconstitution after allogeneic stem cell transplantation: The impact of stem cell source and graft-versus-host disease

Haematologica

Volumn 90, Issue 1, 2005, Pages 86-93

  Abrahamsen, Ingerid Weum ^a   Sømme, Stig ^a   Heldal, Dag ^a   Egeland, Torstein ^a   Kvale, Dag ^b   Tjønnfjord, Geir Erland ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Allogeneic stem cell transplantation; GVHD; Immune reconstitution; Stem cell source

Indexed keywords

BUSULFAN; CD3 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGRAFT; ARTICLE; B LYMPHOCYTE; BONE MARROW; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOID CELL; LYMPHOPOIESIS; MAJOR CLINICAL STUDY; MALE; MYELOID METAPLASIA; NATURAL KILLER CELL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STEM CELL; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 13244273758     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Heldal D, Tjønnfjord G, Brinch L, Albrechtsen D, Egeland T, Steen R, et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 2000;25:1129-36.
2. Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 2001;98:2900-8.
3. Schmitz N, Bacigalupo A, Hasenclever D, Nagler A, Gluckman E, Clark P, et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998;21:995-1003.
4. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001;344:175-81.
5. Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997;54:131-8.
6. Storek J, Espino G, Dawson MA, Storer B, Flowers ME, Maloney DG. Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allofeneic marrow transplantation. Blood 2000;96:3290-3.
7. Storek J, Joseph A, Espino G, Dawson MA, Douek DC, Sullivan KM, et al. Immunity of patients surviving 20-30 years after allogeneic or syngeic bone marrow transplantation. Blood 2001; 98:3505-12.
8. Weaver CH, Longin K, Buckner CD, Bensinger W. Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1994;13:411-5.
9. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead or bone marrow. Blood 1996;88:2775-9.
10. Storek J, Witherspoon RP, Maloney D, Chauncey TR, Storb R. Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. Blood 1997;89:3891-3.
11. Martinez C, Urbano-Ispizua A, Rozman C, Marin P, Rovira M, Sierra J, et al. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts. Exp Hematol 1999;27:561-8.
12. Tjønnfjord G, Steen R, Evensen SA, Thorsby E, Egeland T. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994;84:2795-801.
13. Müller F, Tjønnfjord GE, Nordøy I, Kvale D, Mellbye OJ, Aukrust P, et al. Immunophenotypic analyses of CD34+ cell subsets in bone marrow from HIV-infected patients during highly-active antiretroviral therapy. Eur J Clin Invest 2002;32:535-40.
14. Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Gadeholt G, et al. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints. Bone Marrow Transplant 2002; 29:479-86.
15. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974;18:295-304.
16. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host disease in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
17. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001;97:3380-9.
18. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1 infected humans. Nat Med 1999; 5:83-9.
19. McLean AR, Michie CA. In vivo estimates of division and death rates of human T lymphocytes. Proc Natl Acad Sci USA 1995;92:3707-11.
20. Michie CA, McLean A, Alcock C, Beverly PCL. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992;360:264-5.
21. Storek J, Witherspoon RP. Immunologic reconstitution after hematopoietic stem cell transplantation. In: Atkinson K, ed. Clinical Bone Marrow and Blood Stem Cell Transplantation. Cambridge, United Kingdom: Cambridge University Press; 2000. p. 111-46.
22. George AJ, Ritter MA. Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today 1996; 17:267-72.
23. Muller-Hermelink HK, Sale GE, Borisch B, Storb R. Pathology of the thymus after allogeneic bone marrow transplantationin man. Am J Pathol 1987; 129:242-56.
24. Ritter MA, Ladyman HM. The effects of cyclosporine on the thymic microenvironment and T cell development. In: Kendall MD, editor. Thymus Update Series 4. The thymus in Immunotoxicology. Newark, NJ, USA; Harwood Academic Press. 1991. p. 157-76.
25. Caldwell CW, Poje E, Helikson MA. B cell precursors in normal pediatric bone marrow. Am J Clin Pathol 1991;96:816-21.
26. Storek J, Witherspoon RP, Webb D, Storb R. Lack of B cell precursors in marrow-transplant recipients with chronic graft-versus-host disease. Am J Hematol 1996;52:82-9.
27. Storek J, Wells D, Dawson MA, Storer B, Maloney DG. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 2001; 98:489-91.
28. Cooper MA, Fehniger TA, Caligiuri MA. Biology of human natural killer cell subsets. Trends Immunol 2001; 22:633-40.
29. Shenoy S, Mohanakumar T, Todd G, Westhoff W, Dunnigan K, Adkins DR, et al. Immune reconstitution following allogeneic peripheral blood stem cell transplants. Bone Marrow Transplant 1999;23:335-46.